aluates Reports

$ 0.0

Automative

Global Monoclonal Antibody Drug Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-11B13511

Global Monoclonal Antibody Drug Market Research Report 2023

BUY CHAPTERS

Global Monoclonal Antibody Drug Market Research Report 2025

Code: QYRE-Auto-11B13511

Report

May 2025

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Johnson & Johnson

Roche

Ono Pharmaceutical

Amgen Inc

Merck

Jiangsu Hengrui Pharmaceuticals

BeiGene Ltd

Shanghai Junshi Biosciences

Innovent Biologics

Wuxi Biologics (Cayman)

Shanghai Henlius Biotech

Akeso, Inc.

Lepu Biopharma

CStone Pharmaceuticals

ALPHAMAB ONCOLOGY

Novartis

Takeda Pharmaceutical

Hillhouse Investment Management

Monoclonal Antibody Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Monoclonal Antibody Drug Market

The global market for Monoclonal Antibody Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Drug.

The Monoclonal Antibody Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibody Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoclonal Antibody Drug Market Report

Report Metric	Details
Report Name	Monoclonal Antibody Drug Market
CAGR	5%
Segment by Type	Humanized Monoclonal Antibody Drugs Fully Human Monoclonal Antibody Drugs Small Molecule Antibody Drugs Chimeric Monoclonal Antibody Drugs Other
Segment by Application	Cancer Treatment Autoimmune Disease Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Johnson & Johnson, Roche, Ono Pharmaceutical, Amgen, Merck, Jiangsu Hengrui Pharmaceuticals, Beigene, Shanghai Junshi Biosciences, Innovent Biologics, WuXi Biologics (Cayman), Shanghai Henlius Biotech, Akeso, Lepu Biopharma, CStone Pharmaceuticals, Hillhouse Investment Management, Alphamab Oncology, Novartis, Takeda Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Monoclonal Antibody Drug Market report?

Ans: The main players in the Monoclonal Antibody Drug Market are Abbott, Johnson & Johnson, Roche, Ono Pharmaceutical, Amgen, Merck, Jiangsu Hengrui Pharmaceuticals, Beigene, Shanghai Junshi Biosciences, Innovent Biologics, WuXi Biologics (Cayman), Shanghai Henlius Biotech, Akeso, Lepu Biopharma, CStone Pharmaceuticals, Hillhouse Investment Management, Alphamab Oncology, Novartis, Takeda Pharmaceutical

What are the Application segmentation covered in the Monoclonal Antibody Drug Market report?

Ans: The Applications covered in the Monoclonal Antibody Drug Market report are Cancer Treatment, Autoimmune Disease Treatment

What are the Type segmentation covered in the Monoclonal Antibody Drug Market report?

Ans: The Types covered in the Monoclonal Antibody Drug Market report are Humanized Monoclonal Antibody Drugs, Fully Human Monoclonal Antibody Drugs, Small Molecule Antibody Drugs, Chimeric Monoclonal Antibody Drugs, Other

Recommended Reports

Drug and Antibody Markets

Diagnostics and Testing

Services and Software

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Monoclonal Antibody Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Humanized Monoclonal Antibody Drugs

1.2.3 Fully Human Monoclonal Antibody Drugs

1.2.4 Small Molecule Antibody Drugs

1.2.5 Chimeric Monoclonal Antibody Drugs

1.2.6 Other

1.3 Market by Application

1.3.1 Global Monoclonal Antibody Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer Treatment

1.3.3 Autoimmune Disease Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Monoclonal Antibody Drug Market Perspective (2020-2031)

2.2 Global Monoclonal Antibody Drug Growth Trends by Region

2.2.1 Global Monoclonal Antibody Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Monoclonal Antibody Drug Historic Market Size by Region (2020-2025)

2.2.3 Monoclonal Antibody Drug Forecasted Market Size by Region (2026-2031)

2.3 Monoclonal Antibody Drug Market Dynamics

2.3.1 Monoclonal Antibody Drug Industry Trends

2.3.2 Monoclonal Antibody Drug Market Drivers

2.3.3 Monoclonal Antibody Drug Market Challenges

2.3.4 Monoclonal Antibody Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Monoclonal Antibody Drug Players by Revenue

3.1.1 Global Top Monoclonal Antibody Drug Players by Revenue (2020-2025)

3.1.2 Global Monoclonal Antibody Drug Revenue Market Share by Players (2020-2025)

3.2 Global Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Monoclonal Antibody Drug Revenue

3.4 Global Monoclonal Antibody Drug Market Concentration Ratio

3.4.1 Global Monoclonal Antibody Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Drug Revenue in 2024

3.5 Global Key Players of Monoclonal Antibody Drug Head office and Area Served

3.6 Global Key Players of Monoclonal Antibody Drug, Product and Application

3.7 Global Key Players of Monoclonal Antibody Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Drug Breakdown Data by Type

4.1 Global Monoclonal Antibody Drug Historic Market Size by Type (2020-2025)

4.2 Global Monoclonal Antibody Drug Forecasted Market Size by Type (2026-2031)

5 Monoclonal Antibody Drug Breakdown Data by Application

5.1 Global Monoclonal Antibody Drug Historic Market Size by Application (2020-2025)

5.2 Global Monoclonal Antibody Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Monoclonal Antibody Drug Market Size (2020-2031)

6.2 North America Monoclonal Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Monoclonal Antibody Drug Market Size by Country (2020-2025)

6.4 North America Monoclonal Antibody Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Monoclonal Antibody Drug Market Size (2020-2031)

7.2 Europe Monoclonal Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Monoclonal Antibody Drug Market Size by Country (2020-2025)

7.4 Europe Monoclonal Antibody Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Monoclonal Antibody Drug Market Size (2020-2031)

8.2 Asia-Pacific Monoclonal Antibody Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Monoclonal Antibody Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Monoclonal Antibody Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Monoclonal Antibody Drug Market Size (2020-2031)

9.2 Latin America Monoclonal Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Monoclonal Antibody Drug Market Size by Country (2020-2025)

9.4 Latin America Monoclonal Antibody Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Monoclonal Antibody Drug Market Size (2020-2031)

10.2 Middle East & Africa Monoclonal Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Monoclonal Antibody Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Monoclonal Antibody Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Monoclonal Antibody Drug Introduction

11.1.4 Abbott Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Monoclonal Antibody Drug Introduction

11.2.4 Johnson & Johnson Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Monoclonal Antibody Drug Introduction

11.3.4 Roche Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Ono Pharmaceutical

11.4.1 Ono Pharmaceutical Company Details

11.4.2 Ono Pharmaceutical Business Overview

11.4.3 Ono Pharmaceutical Monoclonal Antibody Drug Introduction

11.4.4 Ono Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.4.5 Ono Pharmaceutical Recent Development

11.5 Amgen

11.5.1 Amgen Company Details

11.5.2 Amgen Business Overview

11.5.3 Amgen Monoclonal Antibody Drug Introduction

11.5.4 Amgen Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.5.5 Amgen Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Monoclonal Antibody Drug Introduction

11.6.4 Merck Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.6.5 Merck Recent Development

11.7 Jiangsu Hengrui Pharmaceuticals

11.7.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.7.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.7.3 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Introduction

11.7.4 Jiangsu Hengrui Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.7.5 Jiangsu Hengrui Pharmaceuticals Recent Development

11.8 Beigene

11.8.1 Beigene Company Details

11.8.2 Beigene Business Overview

11.8.3 Beigene Monoclonal Antibody Drug Introduction

11.8.4 Beigene Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.8.5 Beigene Recent Development

11.9 Shanghai Junshi Biosciences

11.9.1 Shanghai Junshi Biosciences Company Details

11.9.2 Shanghai Junshi Biosciences Business Overview

11.9.3 Shanghai Junshi Biosciences Monoclonal Antibody Drug Introduction

11.9.4 Shanghai Junshi Biosciences Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.9.5 Shanghai Junshi Biosciences Recent Development

11.10 Innovent Biologics

11.10.1 Innovent Biologics Company Details

11.10.2 Innovent Biologics Business Overview

11.10.3 Innovent Biologics Monoclonal Antibody Drug Introduction

11.10.4 Innovent Biologics Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.10.5 Innovent Biologics Recent Development

11.11 WuXi Biologics (Cayman)

11.11.1 WuXi Biologics (Cayman) Company Details

11.11.2 WuXi Biologics (Cayman) Business Overview

11.11.3 WuXi Biologics (Cayman) Monoclonal Antibody Drug Introduction

11.11.4 WuXi Biologics (Cayman) Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.11.5 WuXi Biologics (Cayman) Recent Development

11.12 Shanghai Henlius Biotech

11.12.1 Shanghai Henlius Biotech Company Details

11.12.2 Shanghai Henlius Biotech Business Overview

11.12.3 Shanghai Henlius Biotech Monoclonal Antibody Drug Introduction

11.12.4 Shanghai Henlius Biotech Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.12.5 Shanghai Henlius Biotech Recent Development

11.13 Akeso

11.13.1 Akeso Company Details

11.13.2 Akeso Business Overview

11.13.3 Akeso Monoclonal Antibody Drug Introduction

11.13.4 Akeso Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.13.5 Akeso Recent Development

11.14 Lepu Biopharma

11.14.1 Lepu Biopharma Company Details

11.14.2 Lepu Biopharma Business Overview

11.14.3 Lepu Biopharma Monoclonal Antibody Drug Introduction

11.14.4 Lepu Biopharma Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.14.5 Lepu Biopharma Recent Development

11.15 CStone Pharmaceuticals

11.15.1 CStone Pharmaceuticals Company Details

11.15.2 CStone Pharmaceuticals Business Overview

11.15.3 CStone Pharmaceuticals Monoclonal Antibody Drug Introduction

11.15.4 CStone Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.15.5 CStone Pharmaceuticals Recent Development

11.16 Hillhouse Investment Management

11.16.1 Hillhouse Investment Management Company Details

11.16.2 Hillhouse Investment Management Business Overview

11.16.3 Hillhouse Investment Management Monoclonal Antibody Drug Introduction

11.16.4 Hillhouse Investment Management Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.16.5 Hillhouse Investment Management Recent Development

11.17 Alphamab Oncology

11.17.1 Alphamab Oncology Company Details

11.17.2 Alphamab Oncology Business Overview

11.17.3 Alphamab Oncology Monoclonal Antibody Drug Introduction

11.17.4 Alphamab Oncology Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.17.5 Alphamab Oncology Recent Development

11.18 Novartis

11.18.1 Novartis Company Details

11.18.2 Novartis Business Overview

11.18.3 Novartis Monoclonal Antibody Drug Introduction

11.18.4 Novartis Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.18.5 Novartis Recent Development

11.19 Takeda Pharmaceutical

11.19.1 Takeda Pharmaceutical Company Details

11.19.2 Takeda Pharmaceutical Business Overview

11.19.3 Takeda Pharmaceutical Monoclonal Antibody Drug Introduction

11.19.4 Takeda Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2020-2025)

11.19.5 Takeda Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Johnson & Johnson

Roche

Ono Pharmaceutical

Amgen Inc

Merck

Jiangsu Hengrui Pharmaceuticals

BeiGene Ltd

Shanghai Junshi Biosciences

Innovent Biologics

Wuxi Biologics (Cayman)

Shanghai Henlius Biotech

Akeso, Inc.

Lepu Biopharma

CStone Pharmaceuticals

ALPHAMAB ONCOLOGY

Novartis

Takeda Pharmaceutical

Hillhouse Investment Management

List of Tables

Table 1. Global Monoclonal Antibody Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Humanized Monoclonal Antibody Drugs

Table 3. Key Players of Fully Human Monoclonal Antibody Drugs

Table 4. Key Players of Small Molecule Antibody Drugs

Table 5. Key Players of Chimeric Monoclonal Antibody Drugs

Table 6. Key Players of Other

Table 7. Global Monoclonal Antibody Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Monoclonal Antibody Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Monoclonal Antibody Drug Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Monoclonal Antibody Drug Market Share by Region (2020-2025)

Table 11. Global Monoclonal Antibody Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Monoclonal Antibody Drug Market Share by Region (2026-2031)

Table 13. Monoclonal Antibody Drug Market Trends

Table 14. Monoclonal Antibody Drug Market Drivers

Table 15. Monoclonal Antibody Drug Market Challenges

Table 16. Monoclonal Antibody Drug Market Restraints

Table 17. Global Monoclonal Antibody Drug Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Monoclonal Antibody Drug Market Share by Players (2020-2025)

Table 19. Global Top Monoclonal Antibody Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2024)

Table 20. Ranking of Global Top Monoclonal Antibody Drug Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Monoclonal Antibody Drug Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Monoclonal Antibody Drug, Headquarters and Area Served

Table 23. Global Key Players of Monoclonal Antibody Drug, Product and Application

Table 24. Global Key Players of Monoclonal Antibody Drug, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Monoclonal Antibody Drug Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Monoclonal Antibody Drug Revenue Market Share by Type (2020-2025)

Table 28. Global Monoclonal Antibody Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Monoclonal Antibody Drug Revenue Market Share by Type (2026-2031)

Table 30. Global Monoclonal Antibody Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Monoclonal Antibody Drug Revenue Market Share by Application (2020-2025)

Table 32. Global Monoclonal Antibody Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Monoclonal Antibody Drug Revenue Market Share by Application (2026-2031)

Table 34. North America Monoclonal Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Monoclonal Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Monoclonal Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Monoclonal Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Monoclonal Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Monoclonal Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Monoclonal Antibody Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Monoclonal Antibody Drug Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Monoclonal Antibody Drug Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Monoclonal Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Monoclonal Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Monoclonal Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Monoclonal Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Monoclonal Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Monoclonal Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbott Company Details

Table 50. Abbott Business Overview

Table 51. Abbott Monoclonal Antibody Drug Product

Table 52. Abbott Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 53. Abbott Recent Development

Table 54. Johnson & Johnson Company Details

Table 55. Johnson & Johnson Business Overview

Table 56. Johnson & Johnson Monoclonal Antibody Drug Product

Table 57. Johnson & Johnson Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 58. Johnson & Johnson Recent Development

Table 59. Roche Company Details

Table 60. Roche Business Overview

Table 61. Roche Monoclonal Antibody Drug Product

Table 62. Roche Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 63. Roche Recent Development

Table 64. Ono Pharmaceutical Company Details

Table 65. Ono Pharmaceutical Business Overview

Table 66. Ono Pharmaceutical Monoclonal Antibody Drug Product

Table 67. Ono Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 68. Ono Pharmaceutical Recent Development

Table 69. Amgen Company Details

Table 70. Amgen Business Overview

Table 71. Amgen Monoclonal Antibody Drug Product

Table 72. Amgen Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 73. Amgen Recent Development

Table 74. Merck Company Details

Table 75. Merck Business Overview

Table 76. Merck Monoclonal Antibody Drug Product

Table 77. Merck Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 78. Merck Recent Development

Table 79. Jiangsu Hengrui Pharmaceuticals Company Details

Table 80. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 81. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product

Table 82. Jiangsu Hengrui Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 83. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 84. Beigene Company Details

Table 85. Beigene Business Overview

Table 86. Beigene Monoclonal Antibody Drug Product

Table 87. Beigene Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 88. Beigene Recent Development

Table 89. Shanghai Junshi Biosciences Company Details

Table 90. Shanghai Junshi Biosciences Business Overview

Table 91. Shanghai Junshi Biosciences Monoclonal Antibody Drug Product

Table 92. Shanghai Junshi Biosciences Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 93. Shanghai Junshi Biosciences Recent Development

Table 94. Innovent Biologics Company Details

Table 95. Innovent Biologics Business Overview

Table 96. Innovent Biologics Monoclonal Antibody Drug Product

Table 97. Innovent Biologics Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 98. Innovent Biologics Recent Development

Table 99. WuXi Biologics (Cayman) Company Details

Table 100. WuXi Biologics (Cayman) Business Overview

Table 101. WuXi Biologics (Cayman) Monoclonal Antibody Drug Product

Table 102. WuXi Biologics (Cayman) Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 103. WuXi Biologics (Cayman) Recent Development

Table 104. Shanghai Henlius Biotech Company Details

Table 105. Shanghai Henlius Biotech Business Overview

Table 106. Shanghai Henlius Biotech Monoclonal Antibody Drug Product

Table 107. Shanghai Henlius Biotech Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 108. Shanghai Henlius Biotech Recent Development

Table 109. Akeso Company Details

Table 110. Akeso Business Overview

Table 111. Akeso Monoclonal Antibody Drug Product

Table 112. Akeso Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 113. Akeso Recent Development

Table 114. Lepu Biopharma Company Details

Table 115. Lepu Biopharma Business Overview

Table 116. Lepu Biopharma Monoclonal Antibody Drug Product

Table 117. Lepu Biopharma Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 118. Lepu Biopharma Recent Development

Table 119. CStone Pharmaceuticals Company Details

Table 120. CStone Pharmaceuticals Business Overview

Table 121. CStone Pharmaceuticals Monoclonal Antibody Drug Product

Table 122. CStone Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 123. CStone Pharmaceuticals Recent Development

Table 124. Hillhouse Investment Management Company Details

Table 125. Hillhouse Investment Management Business Overview

Table 126. Hillhouse Investment Management Monoclonal Antibody Drug Product

Table 127. Hillhouse Investment Management Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 128. Hillhouse Investment Management Recent Development

Table 129. Alphamab Oncology Company Details

Table 130. Alphamab Oncology Business Overview

Table 131. Alphamab Oncology Monoclonal Antibody Drug Product

Table 132. Alphamab Oncology Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 133. Alphamab Oncology Recent Development

Table 134. Novartis Company Details

Table 135. Novartis Business Overview

Table 136. Novartis Monoclonal Antibody Drug Product

Table 137. Novartis Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 138. Novartis Recent Development

Table 139. Takeda Pharmaceutical Company Details

Table 140. Takeda Pharmaceutical Business Overview

Table 141. Takeda Pharmaceutical Monoclonal Antibody Drug Product

Table 142. Takeda Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2020-2025) & (US$ Million)

Table 143. Takeda Pharmaceutical Recent Development

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

Table 147. Authors List of This Report

List of Figures

Figure 1. Monoclonal Antibody Drug Picture

Figure 2. Global Monoclonal Antibody Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Monoclonal Antibody Drug Market Share by Type: 2024 VS 2031

Figure 4. Humanized Monoclonal Antibody Drugs Features

Figure 5. Fully Human Monoclonal Antibody Drugs Features

Figure 6. Small Molecule Antibody Drugs Features

Figure 7. Chimeric Monoclonal Antibody Drugs Features

Figure 8. Other Features

Figure 9. Global Monoclonal Antibody Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Monoclonal Antibody Drug Market Share by Application: 2024 VS 2031

Figure 11. Cancer Treatment Case Studies

Figure 12. Autoimmune Disease Treatment Case Studies

Figure 13. Monoclonal Antibody Drug Report Years Considered

Figure 14. Global Monoclonal Antibody Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Monoclonal Antibody Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Monoclonal Antibody Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Monoclonal Antibody Drug Market Share by Players in 2024

Figure 18. Global Top Monoclonal Antibody Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Monoclonal Antibody Drug Revenue in 2024

Figure 20. North America Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Monoclonal Antibody Drug Market Share by Country (2020-2031)

Figure 22. United States Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Monoclonal Antibody Drug Market Share by Country (2020-2031)

Figure 26. Germany Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Monoclonal Antibody Drug Market Share by Region (2020-2031)

Figure 34. China Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Monoclonal Antibody Drug Market Share by Country (2020-2031)

Figure 42. Mexico Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Monoclonal Antibody Drug Market Share by Country (2020-2031)

Figure 46. Turkey Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Monoclonal Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Abbott Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 52. Ono Pharmaceutical Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 53. Amgen Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 54. Merck Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 55. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 56. Beigene Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 57. Shanghai Junshi Biosciences Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 58. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 59. WuXi Biologics (Cayman) Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 60. Shanghai Henlius Biotech Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 61. Akeso Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 62. Lepu Biopharma Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 63. CStone Pharmaceuticals Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 64. Hillhouse Investment Management Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 65. Alphamab Oncology Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 66. Novartis Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 67. Takeda Pharmaceutical Revenue Growth Rate in Monoclonal Antibody Drug Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Next Generation Antibody Drug Market Research Report 2024

Antibody Drug Conjugate Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Drug Conjugation Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune Drugs Market Insights Forecast to 2030

Antibody Drug Conjugate Linker And Conjugation Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Grade Antibody Portfolio Market Research Report 2025

Global Targeted Drugs for Multiple Myeloma Market Research Report 2024

Global Monoclonal Antibodies Product Market Research Report 2024

Diagnostic Specialty Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Guidewire Market Research Report 2024

Global Still s Disease Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions